Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (931-940 of 1,467) with videos related to

Pageof 147
Sort By:
Annals of the Rheumatic Diseases|January 17, 2014
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trialJ S Smolen, P Emery, G F Ferraccioli, et al.
Neurologia I Neurochirurgia Polska|February 11, 2015
Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - a pilot studyPrzemyslaw Zadora, Wojciech Dabrowski, Katarzyna Czarko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Arthritis and Rheumatism|January 20, 2004
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destructionJochen Zwerina, Silvia Hayer, Makiyeh Tohidast-Akrad, et al.
Annals of the Rheumatic Diseases|November 18, 2017
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritisArthur Kavanaugh, Ronald F van Vollenhoven, Roy Fleischmann, et al.
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Development and Psychopathology|December 29, 2016
Parenting and adolescents' psychological adjustment: Longitudinal moderation by adolescents' genetic sensitivityClare M Stocker, April S Masarik, Keith F Widaman, et al.
Rheumatology and Therapy|June 23, 2019
Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib TrialKaleb Michaud, Janet E Pope, Paul Emery, et al.
Annals of the Rheumatic Diseases|January 10, 2014
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Cécile Gaujoux-Viala, Jackie L Nam, et al.
RMD Open|June 22, 2023
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforceGabriele De Marco, Alen Zabotti, Xenofon Baraliakos, et al.
Pageof 147

Showing results (931-940 of 1,467) with videos related to

Sort By:
Pageof 147
Annals of the Rheumatic Diseases|January 17, 2014
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trialJ S Smolen, P Emery, G F Ferraccioli, et al.
Neurologia I Neurochirurgia Polska|February 11, 2015
Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor - a pilot studyPrzemyslaw Zadora, Wojciech Dabrowski, Katarzyna Czarko, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 21, 2024
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical ResponsesOliver FitzGerald, Dafna D Gladman, Philip J Mease, et al.
Arthritis and Rheumatism|January 20, 2004
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destructionJochen Zwerina, Silvia Hayer, Makiyeh Tohidast-Akrad, et al.
Annals of the Rheumatic Diseases|November 18, 2017
Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritisArthur Kavanaugh, Ronald F van Vollenhoven, Roy Fleischmann, et al.
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Development and Psychopathology|December 29, 2016
Parenting and adolescents' psychological adjustment: Longitudinal moderation by adolescents' genetic sensitivityClare M Stocker, April S Masarik, Keith F Widaman, et al.
Rheumatology and Therapy|June 23, 2019
Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib TrialKaleb Michaud, Janet E Pope, Paul Emery, et al.
Annals of the Rheumatic Diseases|January 10, 2014
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Cécile Gaujoux-Viala, Jackie L Nam, et al.
RMD Open|June 22, 2023
Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforceGabriele De Marco, Alen Zabotti, Xenofon Baraliakos, et al.
Pageof 147